Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD

OBJECTIVE:The aim of the present study was to determine the predictive value of olfactory dysfunction for the early development of a synuclein-mediated neurodegenerative disease in subjects with idiopathic REM sleep behavior disorder (iRBD) over an observational period of 5 years. METHODS:Thirty-fou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2015-02, Vol.84 (7), p.654-658
Hauptverfasser: Mahlknecht, Philipp, Iranzo, Alex, Högl, Birgit, Frauscher, Birgit, Müller, Christoph, Santamaría, Joan, Tolosa, Eduardo, Serradell, Monica, Mitterling, Thomas, Gschliesser, Viola, Goebel, Georg, Brugger, Florian, Scherfler, Christoph, Poewe, Werner, Seppi, Klaus
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVE:The aim of the present study was to determine the predictive value of olfactory dysfunction for the early development of a synuclein-mediated neurodegenerative disease in subjects with idiopathic REM sleep behavior disorder (iRBD) over an observational period of 5 years. METHODS:Thirty-four patients with polysomnography-confirmed iRBD underwent olfactory testing using the entire Sniffinʼ Sticks test assessing odor identification, odor discrimination, and olfactory threshold. Patients with iRBD were prospectively followed up over a period of 4.9 ± 0.3 years (mean ± SD). The diagnosis of neurodegenerative diseases was based on current clinical diagnostic criteria. RESULTS:After 2.4 ± 1.7 years (mean ± SD), 9 patients (26.5%) with iRBD developed a Lewy body disease (6 Parkinson disease and 3 dementia with Lewy bodies). The entire Sniffinʼ Sticks test and the identification subtest had the same overall diagnostic accuracy of 82.4% (95% confidence interval66.1%–92.0%) in predicting conversion. The relative risk for a Lewy body disease in the lowest tertile of olfactory function was 7.3 (95% confidence interval1.8–29.6) compared with the top 2 tertiles. CONCLUSIONS:Assessment of olfactory function, particularly odor identification, may help to predict the development of a Lewy body disease in patients with iRBD over a relatively short time period and thus to identify patients suitable for future disease modification trials.
ISSN:0028-3878
1526-632X
DOI:10.1212/WNL.0000000000001265